June 2026 – Kinstellar has advised Catalyst Romania Fund II on its Series A investment in the Austrian company SOMAREALITY.
The round was led by Catalyst Romania Fund II, with participation from existing investors MT-Lab, RDY Ventures, Moondust Ventures, and Gateway Ventures. This marks the thirteenth investment for Catalyst Romania Fund II.
SOMAREALITY is a Vienna-based deep tech company developing eye tracking-based software solutions to measure cognitive states such as cognitive load, attention, perception, fatigue, and overall performance in real time. Since launching its first biomarker in 2024, the company has generated over EUR 2 million in B2B revenue and gained traction in several industries including aviation, healthcare, professional sports, and research.
The proceeds from the funding round will be used to expand existing B2B segments, support longitudinal studies focused on cognitive health and human performance, and enable a planned expansion into the B2C market.
Alin Stanciu, Partner at Catalyst Romania
Kinstellar advised Catalyst Romania Fund II on all legal aspects of the transaction.
The Kinstellar team was led by Patricia Backhausen (Partner) and Selina Pichler (Associate) with support from Hartwig Kienast (Partner), Sebastian Reiter (Partner), Harald Strahberger (Partner), Laurenz Liedermann (Partner), Benedikt Sprinzl (Partner), Sandra Seldte (Counsel), Agnes Lackenberger (Associate), Florian Sesztak (Associate), Sang Wha Lee (Head of Korean Desk), and Alexander Knobl (Associate).